Novartis AG
Methods for treating gastrointestinal disorders using FXR agonists

Abstract:

The invention provides methods for modulating the activity of farnesoid X receptors (FXRs) using specific FXR agonists, in particular for treating or preventing liver and gastrointestinal diseases.